Seroconversion for human herpesvirus 8 during HIV infection is highly predictive of Kaposi's sarcoma

AIDS

Volumn 12, Issue 18, 1998, Pages 2481-2488

  Renwick, Neil ^a   Halaby, Teysir ^a   Weverling, Gerrit J ^a   Dukers, Nicole H T M ^b   Simpson, Guy R ^c   Coutinho, Roel A ^a,b   Lange, Joep M A ^a   Schulz, Thomas F ^c   Goudsmit, Jaap ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b MUNICIPAL HEALTH SERVICE   (Netherlands)

^c UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Epidemiology; HIV; Kaposi's sarcoma; KSHV HHV8; Risk factors; Seroconversion

Indexed keywords

CD4 ANTIGEN; VIRUS ANTIBODY;

ADULT; ARTICLE; DRUG ABUSE; FEMALE; HOMOSEXUALITY; HUMAN; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KAPOSI SARCOMA; LYMPHOCYTE COUNT; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; OPPORTUNISTIC INFECTION; PREDICTION; PRIORITY JOURNAL; RISK FACTOR; SEROCONVERSION;

EID: 0032564627     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199818000-00018     Document Type: Article

References (34)

1. Chang Y, Cesarman E, Possin MS, et al.: Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994, 266:1865-1869.
2. Boshoff C, Schulz TF, Kennedy MM, et al.: Kaposi's sarcoma-associated herpesvirus infects endothelial and spindle cells. Nature Med 1995, 1:1274-1278.
3. Whitby D, Howard MR, Tenant-Flowers M, et al.: Detection of Kaposi's sarcoma associated herpesvirus (KSHV) in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma. Lancet 1995, 346:799-802.
4. Beral V, Peterman TA, Berkelman RL, Jaffe HW: Kaposi's sarcoma among persons with AIDS: a sexually transmitted infection? Lancet 1990, 335:123-128.
5. Lennette EL, Blackbourn DJ, Levy JA: Antibodies to human herpesvirus 8 in the general population and in Kaposi's sarcoma patients. Lancet 1996, 348:858-861.
6. Davis DA, Humphrey RW, Newcomb FM, et al.: Detection of serum antibodies to Kaposi's sarcoma-associated herpesvirus-specific peptide. J Infect Dis 1997, 175:1071-1079.
7. Gao SJ, Kingsley L, Li M, et al.: KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma. Nature Med 1996, 2:925-928.
8. Kedes DH, Operskalski E, Busch M, et al.: The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus): distribution of infection in Kaposi's sarcoma risk groups and evidence for sexual transmission. Nature Med 1996, 2:918-924.
9. Miller G, Rigsby MO, Heston L, et al.: Antibodies to butyrate-inducible antigens of Kaposi's sarcoma-associated herpesvirus in patients with HIV-1 infection. N Engl J Med 1996, 334:1292-1297.
10. Moore PS, Gao SJ, Dominguez G, et al.: Primary characterisation of a herpesvirus agent associated with Kaposi's sarcoma. J Virol 1996, 70:549-558.
11. Simpson GR, Schulz TF, Whitby D, et al.: Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen. Lancet 1996, 349:1133-1138.
12. Gao SJ, Kingsley L, Hoover DR, et al.: Seroconversion to antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma. N Engl J Med 1996, 335:233-241.
13. Calabrò ML, Sheldon J, Favero A, et al.: Seroprevalence of Kaposi's sarcoma-associated herpesvirus (KSHV HHV8) in different regions of Italy. J Hum Virol 1998, 1:207-213.
14. Whitby D, Luppi M, Barozzi P, Boshoff C, Weiss RA, Torelli G: Human herpesvirus 8 seroprevalence in blood donors and patients with lymphoma from different regions of Italy. J Natl Cancer Inst 1998, 90:395-397.
15. Ariyoshi K, Van der Loeff MS, Corrah T, et al.: Kaposi's sarcoma and human herpesvirus 8 (HHV8) in HIV-1 and HIV-2 infection in the Gambia. J Hum Virol 1998, 1:193-199.
16. IARC Monographs on the evaluation of carcinogenic risks to humans. Vol 67: Human Immunodeficiency Viruses. IARC Press; Lyon, France, 1996.
17. Bayley AC, Chiengsong-Popov R, Dalgleish AG, et al.: HTLV-III serology distinguishes atypical and endemic Kaposi's sarcoma in Africa. Lancet 1985, 1:359-361.
18. Rainbow L, Platt GM, Simpson GR, et al.: The 222- to 234-kilodalton latent nuclear protein (LNA) of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) is encoded by ORF73 and is a component of latency-associated nuclear antigen. J Virol 1997, 71:5915-5921.
19. + cells and the level of core antigens of and antibodies to the human immunodeficiency virus as predictors of AIDS among seropositive homosexual men. J Infect Dis 1988, 158:615-622.
20. van den Hoek JAR, Coutinho RA, van Haastrecht HJA, van Zadelhoff AW, Goudsmit J: Prevalence and risk factors of HIV infections among drug users and drug-using prostitutes in Amsterdam. AIDS 1988, 2:55-60.
21. Anonymous: 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR 1992, 41:56-58.
22. Moore PS, Kingsley LA, Holmberg SD, et al.: Kaposi's sarcoma-associated herpesvirus infection prior to onset of Kaposi's sarcoma. AIDS 1996, 10:175-180.
23. Lefrere JJ, Meyohas MC, Mariotti M, Meynard JL, Thauvin M, Frottier J: Detection of human herpesvirus 8 DNA sequences before the appearance of Kaposi's sarcoma in human immunodeficiency virus (HIV)-positive subjects with a known date of HIV seroconversion. J Infect Dis 1996, 174:283-287.
24. Martin JN, Ganem DE, Osmond DH, Page-Shafer KA, Macrae D, Kedes DH: Sexual transmission and the natural history of human herpesvirus 8 infection. N Engl J Med 1998, 338:948-954.
25. Melbye M, Cook PM, Hjalgrim H, et al.: Transmission of human herpesvirus 8 (HHV8) among homosexual men follows the pattern of a 'Kaposi's sarcoma agent'. Int J Cancer 1998, 12:543-548.
26. Staskus KA, Zhong W, Gebhard K, et al.: Kaposi's sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells. J Virol 1997, 71:715-719.
27. Foreman KE, Bacon PE, His ED, Nickolott BJ: In situ polymerase chain reaction-based localisation studies support role of human herpesvirus 8 as the cause of two AIDS-related neoplasms: Kaposi's sarcoma and body cavity lymphoma. J Clin Invest 1997, 99:2971-2978.
28. Zietz C, Hotz B, Sturzl M, et al.: Aortic endothelium in HIV-1 infection: chronic injury, activation and increased leukocyte adherence. Am J Pathol 1996, 149: 1887-1898.
29. Blasig C, Zietz C, Haar B, et al.: Monocytes in Kaposi's sarcoma lesions are productively infected by human herpesvirus 8. J Virol 1997, 10:7963-7968.
30. Ensoli B, Gendelman R, Markham P, et al.: Synergy between basic fibroblast growth factor and human immunodeficiency virus type 1 Tat protein in induction of Kaposi's sarcoma. Nature 1994, 371:674-680.
31. Harrington W, Sieczkowski L, Sosa C, et al.: Activation of HHV8 by HIV-1 Tat. Lancet 1997, 349:774.
32. Blum L, Pellet C, Agbalika F, et al.: Complete remission of AIDS-related Kaposi's sarcoma associated with undetectable human herpesvirus 8 sequences during anti-HIV protease therapy [letter]. AIDS 1997, 11:1653-1655.
33. Mocroft A, Youle M, Gazzard B, et al.: Anti-herpesvirus treatment and risk of Kaposi's sarcoma in HIV infection. Royal Free/Chelsea and Westminster Hospitals Collaborative Group. AIDS 1996, 10:1101-1105.
34. Glesby MJ, Hoover DR, Weng S, et al.: Use of antiherpes drugs and the risk of Kaposi's sarcoma: data from the Multicenter AIDS Cohort Study. J Infect Dis 1996, 173: 1477-1480.